Application 089407
- Type
- ANDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | POLOCAINE | MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | 1% | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50090-4517 | Polocaine | MEPIVACAINE HYDROCHLORIDE | A-S Medication Solutions | ANDA | Current |
| 50090-4517 | Polocaine | MEPIVACAINE HYDROCHLORIDE | A-S Medication Solutions | ANDA | Current |
| 51662-1534 | POLOCAINE (MEPIVACAINE HCl) | POLOCAINE (MEPIVACAINE HCl) | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1534 | POLOCAINE (MEPIVACAINE HCl) | POLOCAINE (MEPIVACAINE HCl) | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 63323-283 | Polocaine | MEPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-283 | Polocaine | MEPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-283 | Polocaine | MEPIVACAINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | ANDA | Current |